Table 2.
Dose adjustment of study drugs according to renal function
| Creatinine clearance (mL/min) | Dose | Frequency |
| Temocillin (intravenous) | ||
| 30–60 | 1 g | Every 12 hours |
| 10–30 | 1 g | Every 24 hours |
| <10 | 500 mg–1 g | Every 24–48 hours |
| Meropenem (intravenous) | ||
| 26–50 | 1 g | Every 12 hours |
| 10–25 | 500 mg | Every 12 hours |
| <10 | 500 mg | Every 24 hours |
| Ertapenem (intravenous) | ||
| <30 | 1 g | Every 24 hours |
| <30 | Not recommended | |
| Ciprofloxacin (oral) | ||
| >60 | 500 mg | Every 12 hours |
| 30–60 | 250–500 mg | Every 12 hours |
| <30 | 250–500 mg | Every 24 hours |
| Amoxicillin-clavulanic acid (oral) | ||
| 10–30 | 500/150 mg | Every 12 hours |
| <10 | 500/125 mg | Every 24 hours |
| Trimethoprim-sulfamethoxazole (oral) | ||
| >30 | 160/800 mg | Every 12 hours |
| 15–30 | 80/400 mg | Every 12 hours |
| <15 | Not recommended | Not recommended |